Sagimet Biosciences to participate in two upcoming investor conferences
Sagimet Biosciences said management will participate in two upcoming investor conferences, according to the company’s announcement.
FOSTER CITY, Calif., Sept.
02, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.
NASDAQ:SGMT, a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor c…